Auth bypass in Bdtask Pharmacare
CVE-2025-12288
A vulnerability was detected in Bdtask Pharmacy Management System up to 9.4. Affected is an unknown function of the file /user/edit_user/ of the component User Profile Handler. Performing manipulation results in authorization bypass. Remote exploitation of the attack is possible. The exploit is now public and may be used. The vendor was contacted early about this disclosure but did not respond in any way.
Published · last modified .
CVSS v3 metric
CVSS v3 base score 4.3 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N.
EPSS exploit prediction
EPSS: 0.005 (38.7th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 39th percentile — 38.7% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.004 · newest: 0.005 · change: +0.000
Affected products
- Bdtask Pharmacare
- Bdtask Pharmacy Management System — versions 9.0, 9.1, 9.2
Weakness classification (CWE)
References
- vuldb.com/ (VDB Entry, Third Party Advisory, vdb-entry)
- vuldb.com/ (signature, Permissions Required, permissions-required, VDB Entry)
- vuldb.com/ (VDB Entry, Third Party Advisory, third-party-advisory)
- github.com/4m3rr0r/PoCVulDb/blob/main/CVE-2025-12288.md (Exploit, Third Party Advisory, exploit)
Frequently asked questions
- What is CVE-2025-12288?
- CVE-2025-12288 is a medium-severity vulnerability in Bdtask Pharmacare, classified under Improper Authorization. CVSS score: 4.3/10. Published 2025-10-27.
- How severe is CVE-2025-12288?
- Medium severity. CVSS v3 base score is 4.3 out of 10.